States Sue Hims & Hers Over Privacy Practices
Five states join a Federal Trade Commission lawsuit alleging the telehealth company shared sensitive health data with advertisers.
Updated on Nov. 11, 2026 in Healthcare

Live Poll
Do you trust online telehealth companies to keep your health information private?
Arizona, Florida, Nebraska, Ohio and Wisconsin joined a Federal Trade Commission lawsuit against Hims & Hers Health in an amended complaint filed in the US District Court for the Northern District of California. The complaint alleges the company shared consumers' sensitive health information with third-party advertising platforms.
Why it matters
The lawsuit alleges the telehealth company also charges users for prescription drugs before they meet with healthcare providers and makes subscriptions difficult to cancel. The case adds to scrutiny of how digital health platforms handle patient data and billing for weight-loss and other prescription drugs.
The amended complaint adds five states to the action, which the FTC initiated in July alongside Los Angeles County and Utah. Hims & Hers Health also cut its full-year core profit forecast on Monday, citing higher costs tied to a pivot toward branded weight-loss drugs and international expansion, and the filing does not state the financial exposure from the suit.
The players
Federal Trade Commission
The Federal Trade Commission is the independent US agency that enforces consumer protection and antitrust laws, and it initiated this lawsuit against Hims & Hers Health.
Hims & Hers Health
Hims & Hers Health is a publicly traded telehealth company that is one of the largest players in the market for weight-loss drugs and also treats erectile dysfunction, hair loss and mental health conditions.
The details
The lawsuit alleges that Hims & Hers Health shared consumers' sensitive health information with third-party advertising platforms, including Meta Platforms and Snap. It also alleges the company deceives users about billing and cancellation, charging for prescription drugs before users meet healthcare providers and making it difficult to cancel subscriptions. The company treats erectile dysfunction, hair loss and mental health conditions.
Timeline
July: The FTC initiated the lawsuit with Los Angeles County and Utah.
Monday: Hims & Hers Health cut its full-year core profit forecast.
Tuesday: The FTC announced that additional states had joined the lawsuit.
Industry Landscape
The case applies the FTC's Section 5 consumer protection authority to a telehealth company's advertising data sharing and subscription practices. It places the company's pivot toward branded weight-loss drugs within a market where digital platforms face growing regulatory scrutiny over patient information.
Users of telehealth platforms may want to review how their health information is shared with advertising platforms and how subscriptions can be cancelled. Customers buying prescription drugs through online services should understand when billing occurs relative to a provider consultation.
The takeaway
Health data shared with advertisers and billing practices that precede clinical consultations are the central concerns in this case. Readers using digital health services can check privacy settings and cancellation terms before subscribing.
Further reading
For more on the telehealth sector, see Healthcare coverage.
Live Poll
Do you trust online telehealth companies to keep your health information private?










